This company listing is no longer active
Aceragen Balance Sheet Health
Financial Health criteria checks 2/6
Aceragen has a total shareholder equity of $57.3M and total debt of $733.0K, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are $78.5M and $21.1M respectively.
Key information
1.3%
Debt to equity ratio
US$733.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.12m |
| Equity | US$57.35m |
| Total liabilities | US$21.14m |
| Total assets | US$78.49m |
Recent financial health updates
We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24
We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07Recent updates
Idera Pharmaceuticals completes acquisition of Aceragen
Sep 28We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07When Will Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Become Profitable?
Jan 31Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma
Jan 13Could The Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Ownership Structure Tell Us Something Useful?
Dec 27Don't Ignore The Fact That This Insider Just Sold Some Shares In Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Dec 27Idera Pharmaceuticals receives $5M in additional proceeds from private placement
Dec 15We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Nov 25Idera Pharma names new operations chief
Nov 17Idera Pharmaceuticals EPS misses by $0.37
Oct 29Financial Position Analysis
Short Term Liabilities: ACGN's short term assets ($5.6M) do not cover its short term liabilities ($17.9M).
Long Term Liabilities: ACGN's short term assets ($5.6M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: ACGN has more cash than its total debt.
Reducing Debt: ACGN's debt to equity ratio has increased from 0.1% to 1.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ACGN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ACGN has less than a year of cash runway if free cash flow continues to grow at historical rates of 13.3% each year.